TFEB and breast carcinoma: TFEB controls the phenotype and function of TAMs through multiple autophagy/lysosome-dependent and independent pathways, thereby promoting breast tumor development; Conversely, activation of TFEB is expected to be a target for TAMs for tumor immunotherapy strategies including breast cancer (102).